EFEMP1 and Alzheimer disease: 2016). About 200–300 proteins were identified, many of which showed differences between the AD and control groups. Eight proteins (A2GL, APOM, C1QB, C1QC, C1s, FBLN3, PTPRZ and SEZ6) were further verified by an antibody‐based method to have lower levels in AD cases.